Start-Up Previews (4/02)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, The New Wave in Gastroenterology, features profiles of Algenix Inc., IntraPace Inc., MediGus Ltd. and Semorex Inc. Plus these Selected Start-Ups across Health Care: Isogenica Ltd., Opt-e-scrip Inc., Renovis Inc. and Time-Concepts.com LLC.
You may also be interested in...
Just three years after its founding, Chinese cell therapy developer IASO Bio already has two assets in clinical development and the Nanjing firm has recently attracted $60m in financing. In an exclusive interview, its R&D head told Scrip that speed and partnerships are propelling Chinese developers on a trajectory to quickly catch up with the west in the emerging cell-therapy arena.
Updated guidance from England’s National Institute for Health and Care Excellence says two neurostimulation systems for treatment-resistant depression and epilepsy should only be used under special conditions. See what LivaNova’s VP of difficult-to-treat depression, Jonathan Walker, said about it here.